Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(23 sites)
China
Beijing Ditan Hospital Capital Medical University, Beijing, Beijing Municipality Shanghai General Hospital,Shanghai Jiao Tong University, Shanghai, Shanghai Municipality Beijing youan hospital, the capital of the capital, Beijing Tsinghua Changgeng Hospital, Beijing, Beijing The First Affiliated Hospital of Bengbu Medical University, Bengbu The Second Xiangya Hospital, Central South University, Changsha Xiangya Hospital, Central South University, Changsha The First Affiliated Hospital of Chongqing Medical University, Chongqing Three Gorges Hospital affiliated to Chongqing University, Chongqing Guizhou Provincial People's Hospital, Guizhou Hangzhou Xixi Hospital (Hangzhou Sixth People's Hospital), Hangzhou Henan Provincial People's Hospital, Henan Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University, Luzhou Nanchang Ninth Hospital (Nanchang Central Hospital), Nanchang The First Affiliated Hospital of Nanchang University, Nanchang The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital), Nanjing Ningbo Huamei Hospital, University of Chinese Academy of Sciences, Ningbo Huashan Hospital affiliated to Fudan University, Shanghai Shenzhen Third People's Hospital, Shenzhen The First Affiliated Hospital of Xinxiang Medical College, Xinxiang Yanbian University Affiliated Hospital, Yanbian Zhenjiang Third People's Hospita, Zhenjiang Affiliated Hospital of Zunyi Medical University, Zunyi